Hemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors

References

• Petit L, Gibert M, Popoff MR. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999;7:104–110.
   PubMed Web of Science ®Google Scholar
• Li J, Adams V, Bannam TL, et al. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev. 2013;77:208–233.
   PubMed Web of Science ®Google Scholar
• Bokori-Brown M, Savva CG, Fernandes Da Costa SP, et al. Molecular basis of toxicity of Clostridium perfringens epsilon toxin. FEBS J. 2011;278:4589–4601.
   PubMed Web of Science ®Google Scholar
• Stiles BG, Barth G, Barth H, et al. Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man? Toxins. 2013;5:2138–2160.
   PubMed Web of Science ®Google Scholar
• Minami J, Katayama S, Matsushita O, et al. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol. 1997;41:527–535.
   PubMed Web of Science ®Google Scholar
• Bhown AS, Habeerb AF. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin. Biochem Biophys Res Commun. 1977;78:889–896.
   PubMed Web of Science ®Google Scholar
• Goldstein J, Morris We Fau - Loidl CF, Loidl Cf Fau - Tironi-Farinati C, et al. Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLOS One. 2009;4:e7065.
   Web of Science ®Google Scholar
• Shortt SJ, Titball RW, Lindsay CD. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells. Hum Exp Toxicol. 2000;19:108–116.
   PubMed Web of Science ®Google Scholar
• Ivie SE, Fennessey CM, Sheng J, et al. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens epsilon-toxin. PLoS ONE. 2011;6:e17787.
   PubMed Web of Science ®Google Scholar
• Chassin C, Bens M, de Barry J, et al. Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol. 2007;293:F927–37.
   PubMed Web of Science ®Google Scholar
• Petit L, Maier E, Gibert M, et al. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem. 2001;276:15736–15740.
   PubMed Web of Science ®Google Scholar
• Skals M, Jorgensen NR, Leipziger J, et al. Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc Natl Acad Sci USA. 2009;106:4030–4035.
   PubMed Web of Science ®Google Scholar
• Skals M, Leipziger J, Praetorius HA. Haemolysis induced by alpha-toxin from Staphylococcus aureus requires P2X receptor activation. Pflugers Arch. 2011;462:669–679.
   PubMed Web of Science ®Google Scholar
• Munksgaard PS, Vorup-Jensen T, Reinholdt J, et al. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Cell Microbiol. 2012;14:1904–1920.
   PubMed Web of Science ®Google Scholar
• Burnstock G, Fau - Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16:433–440.
   PubMedGoogle Scholar
• Sluyter R. P2X and P2Y receptor signaling in red blood cells. Front mol biosci. 2015;2:60.
   PubMed Web of Science ®Google Scholar
• Kaczmarek-Hajek K, Lorinczi E, Hausmann R, et al. Molecular and functional properties of P2X receptors–recent progress and persisting challenges. Purinergic Signal. 2012;8:375–417.
   PubMed Web of Science ®Google Scholar
• Abbracchio MP, Burnstock G, Boeynaems JM, et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006;58:281–341.
   PubMed Web of Science ®Google Scholar
• Burnstock G. Blood cells: an historical account of the roles of purinergic signalling. Purinergic Signal. 2015;11:411–434.
   PubMed Web of Science ®Google Scholar
• Kang J, Gao J, Yao W, et al. F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability. Hum Vaccin Immunother. 2017;13:1598–1608.
   PubMed Web of Science ®Google Scholar
• Wang L, Olivecrona G, Gotberg M, et al. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res. 2005;96:189–196.
   PubMed Web of Science ®Google Scholar
• Tanneur V, Duranton C, Brand VB, et al. Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J. 2006;20:133–135.
   PubMed Web of Science ®Google Scholar
• Kim YC, Lee JS, Sak K, et al. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochem Pharmacol. 2005;70:266–274.
   PubMed Web of Science ®Google Scholar
• Soto F, Lambrecht G, Nickel P, et al. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. Neuropharmacology. 1999;38:141–149.
   PubMed Web of Science ®Google Scholar
• Seyffert C, Schmalzing G, Markwardt F. Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors. Curr Top Med Chem. 2004;4:1719–1730.
   PubMed Web of Science ®Google Scholar
• Sophocleous RA, Mullany PR, Winter KM, et al. Propensity of red blood cells to undergo P2X7 receptor-mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging. Transfusion (Paris). 2015;55:1946–1954.
   Web of Science ®Google Scholar
• Skals M, Bjaelde RG, Reinholdt J, et al. Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore. J Biol Chem. 2014;289:19098–19109.
   PubMed Web of Science ®Google Scholar
• Bao L, Locovei S, Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 2004;572:65–68.
   PubMed Web of Science ®Google Scholar
• Locovei S, Bao L, Dahl G. Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci USA. 2006;103:7655–7659.
   PubMed Web of Science ®Google Scholar
• Bruzzone R, Barbe MT, Jakob NJ, et al. Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem. 2005;92:1033–1043.
   PubMed Web of Science ®Google Scholar
• Silverman W, Locovei S, Dahl G. Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol. 2008;295:C761–7.
   PubMed Web of Science ®Google Scholar
• Locovei S, Scemes E, Qiu F, et al. Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 2007;581:483–488.
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. Embo J. 2006;25:5071–5082.
   PubMed Web of Science ®Google Scholar
• Orlans ES, Richards CB, Jones VE. Clostridium welchii epsilon-toxin and antitoxin. Immunology. 1960;3:28–44.
   PubMed Web of Science ®Google Scholar
• Lindsay CD. Assessment of aspects of the toxicity of Clostridium perfringens epsilon-toxin using the MDCK cell line. Hum Exp Toxicol. 1996;15:904–908.
   PubMed Web of Science ®Google Scholar
• Nagahama M, Hara H, Fernandez-Miyakawa M, et al. Oligomerization of Clostridium perfringens epsilon-toxin is dependent upon membrane fluidity in liposomes. Biochemistry (Mosc). 2006;45:296–302.
   Web of Science ®Google Scholar
• Sikora J, Orlov SN, Furuya K, et al. Hemolysis is a primary ATP-release mechanism in human erythrocytes. Blood. 2014;124:2150–2157.
   PubMed Web of Science ®Google Scholar
• Petit L, Gibert M, Gillet D, et al. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol. 1997;179:6480–6487.
   PubMed Web of Science ®Google Scholar
• Wilson HL, Wilson SA, Surprenant A, et al. Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem. 2002;277:34017–34023.
   PubMed Web of Science ®Google Scholar
• Kasuya G, Yamaura T, Ma XB, et al. Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel. Nat Commun. 2017;8:876.
   PubMed Web of Science ®Google Scholar
• Gonnord P, Delarasse C, Auger R, et al. Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts. FASEB J. 2009;23:795–805.
   PubMed Web of Science ®Google Scholar
• Alves GG, Machado de Avila RA, Chavez-Olortegui CD, et al. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known. Anaerobe. 2014;30:102–107.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Kang L, Gao S, et al. Expression and purification of functional Clostridium perfringens alpha and epsilon toxins in Escherichia coli. Protein Expr Purif. 2011;77:207–213.
   PubMed Web of Science ®Google Scholar
• Li Q, Xin W, Gao S, et al. A low-toxic site-directed mutant of Clostridium perfringens epsilon-toxin as a potential candidate vaccine against enterotoxemia. Hum Vaccin Immunother. 2013;9:2386–2392.
   PubMed Web of Science ®Google Scholar